Intrinsic Value of S&P & Nasdaq Contact Us

Embecta Corp. EMBC NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
$30.67
+224.2%
Analyst Price Target
$22.50
+137.8%

Embecta Corp. (EMBC) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bearish — 1 Buy, 1 Hold, 2 Sell.

The consensus price target is $22.50 (low: $20.00, high: $25.00), representing an upside of 137.8% from the current price $9.46.

Analysts estimate Earnings Per Share (EPS) of $2.39 and revenue of $1.12B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $1.36 vs est $2.39 (missed -43%). 2025: actual $1.64 vs est $2.93 (missed -43.9%). Analyst accuracy: 23%.

EMBC Stock — 12-Month Price Forecast

$22.50
▲ +137.84% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Embecta Corp., the average price target is $22.50, with a high forecast of $25.00, and a low forecast of $20.00.
The average price target represents a +137.84% change from the last price of $9.46.
Highest Price Target
$25.00
Average Price Target
$22.50
Lowest Price Target
$20.00

EMBC Analyst Ratings

Sell
4
Ratings
1 Buy
1 Hold
2 Sell
Based on 4 analysts giving stock ratings to Embecta Corp. in the past 3 months
Rating breakdown
Buy
1 25%
Hold
1 25%
Sell
2 50%
25%
Buy
1 analysts
25%
Hold
1 analysts
50%
Sell
2 analysts

EPS Estimates — EMBC

23%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $1.36 vs Est $2.39 ▼ 75.4% off
2025 Actual $1.64 vs Est $2.93 ▼ 78.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — EMBC

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $1.123B vs Est $1.115B ▲ 0.8% off
2025 Actual $1.080B vs Est $1.082B ▼ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message